AAA December 2010 – Page 8

GSK sets aside £50m for UK deals

GlaxoSmithKline (GSK), a UK-listed drugs company, has set aside £50m ($78m) to launch a corporate venturing fund for the country’s early-stage healthcare companies and spin-outs from universities. The UK Venture Capital Fund will be part of GSK’s existing corporate venturing unit, SR One, and is similar in scope to semiconductor company Intel’s launch of regional… Continue reading GSK sets aside £50m for UK deals